Govindarajan Rajagopalan Selected Research

HLA-DQ8 antigen

1/2014	The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia.
5/2007	Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans.
2/2006	Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
2/2003	Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules.
7/2002	Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Govindarajan Rajagopalan Research Topics

Disease

13	Septic Shock (Toxic Shock Syndrome) 01/2020 - 11/2004
6	Inflammation (Inflammations) 10/2018 - 02/2006
5	Infections 01/2021 - 10/2006
5	Autoimmune Diseases (Autoimmune Disease) 10/2018 - 04/2006
5	Pneumonia (Pneumonitis) 10/2017 - 06/2012
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 11/2002
5	Shock 06/2012 - 07/2002
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2015 - 01/2008
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2015 - 11/2011
2	Bacteremia 08/2019 - 08/2015
2	Neoplasms (Cancer) 01/2018 - 06/2010
2	Foodborne Diseases 06/2010 - 12/2008
1	COVID-19 01/2020
1	Cytokine Release Syndrome 01/2020
1	Immunoglobulin G4-Related Disease 10/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2017
1	Wounds and Injuries (Trauma) 12/2015
1	Wound Infection (Wound Infections) 12/2015
1	Glomerulonephritis 11/2015
1	Lupus Nephritis 11/2015
1	Neoplasm Metastasis (Metastasis) 10/2015
1	Melanoma (Melanoma, Malignant) 10/2015
1	Endocarditis 06/2014
1	Hyperglycemia 01/2013
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 06/2012
1	Sialadenitis 05/2007
1	Colitis 04/2006
1	Necrosis 02/2003

Drug/Important Bio-Agent (IBA)

19	SuperantigensIBA 01/2020 - 11/2004
9	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 10/2017 - 11/2002
8	staphylococcal enterotoxin BIBA 01/2021 - 11/2004
6	CytokinesIBA 06/2012 - 11/2004
5	HLA-DQ8 antigenIBA 01/2014 - 07/2002
4	ExotoxinsIBA 12/2015 - 02/2007
4	HLA Antigens (Human Leukocyte Antigens)IBA 10/2012 - 11/2002
3	AntibodiesIBA 01/2020 - 01/2011
2	InterferonsIBA 01/2020 - 02/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018 - 05/2017
2	Linezolid (Zyvox)FDA Link 10/2017 - 10/2012
2	Peptides (Polypeptides)IBA 10/2015 - 11/2004
2	Enterotoxins (Enterotoxin)IBA 06/2014 - 06/2012
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	AutoantigensIBA 10/2018
1	Rituximab (Mabthera)FDA Link 10/2018
1	AutoantibodiesIBA 10/2018
1	SteroidsIBA 10/2018
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2018
1	Bacterial Proteins (Bacterial Protein)IBA 10/2017
1	Immunoglobulin G (IgG)IBA 10/2017
1	Immunoglobulin Fc FragmentsIBA 10/2017
1	Budesonide (Pulmicort)FDA LinkGeneric 05/2017
1	Formoterol Fumarate (Oxis)FDA Link 05/2017
1	2,6-dinitrotoluene (DNT)IBA 01/2017
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 11/2015
1	AntigensIBA 10/2015
1	Staphylococcal enterotoxin FIBA 06/2014
1	EnzymesIBA 06/2014
1	ImmunosorbentsIBA 06/2014
1	lipoteichoic acidIBA 01/2014
1	Peptidoglycan (Murein)IBA 01/2014
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2014
1	Lipoproteins (Lipoprotein)IBA 01/2014
1	Caseins (Casein)FDA Link 01/2013
1	Glutens (Glutelin)IBA 01/2013
1	Vancomycin FDA LinkGeneric 10/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2012
1	Biological ProductsIBA 06/2012
1	ChemokinesIBA 06/2012
1	HLA-D AntigensIBA 11/2011
1	Interferon-gamma (Interferon, gamma)IBA 02/2011
1	NF-kappa B (NF-kB)IBA 06/2010
1	LipopolysaccharidesIBA 06/2010
1	Proteasome InhibitorsIBA 06/2010
1	Bortezomib (Velcade)FDA Link 06/2010
1	Biological Warfare AgentsIBA 06/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2008
1	HLA-DR Antigens (HLA-DR)IBA 01/2008
1	Histocompatibility Antigens Class IIIBA 05/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2007
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2007
1	Interleukin-10 (Interleukin 10)IBA 04/2006
1	InterleukinsIBA 04/2006
1	Freund's AdjuvantIBA 04/2006
1	Streptozocin (Streptozotocin)FDA Link 09/2003
1	Insulin (Novolin)FDA Link 02/2003
1	CarcinogensIBA 02/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 06/2012
1	Artificial Respiration (Mechanical Ventilation) 05/2017
1	Immunotherapy 10/2015
1	Catheters 08/2015
1	Gluten-Free Diet 01/2013
1	Drug Therapy (Chemotherapy) 06/2010
1	Intravaginal Administration 02/2007
1	Intranasal Administration 02/2006